B
Last Price
52 Week Range
HK$0.49 - HK$0.75
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | HK$197.21M |
EV | HK$214.52M |
Shares Outstanding | 402.46M |
Beta | -0.09 |
Industry | Medical - Care Facilities |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2026E | - |
P/Revenue 2026E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2026E | - |
Net Profit Margin 2026E | - |
ROE 2026E | - |
ROCE 2025 | 7.84% |
DPS 2026E | - |
Payout Ratio 2026E | - |
Div. Yield 2026E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Bamboos Health Care Holdings Limited
2293
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Hai, Hiu Chu
Employees
80
Website
www.bamboos.com.hkIPO Date
2014-07-08
Headquarters
Good Hope Building, Unit 901, 9/F, No. 612–618 Nathan Road, Mong Kok, Kowloon Hong Kong
The last closing price of Bamboos Health Care Holdings (2293) is HK$0.49, reflecting a -2.00% change from the prior session. Last updated: January 1, 2026 at 3:01 AM Eastern Time
Review the recent 2293 stock performance trends:Past 1 Month: Bamboos Health Care Holdings (2293) shares have -9.26%.Past 3 Months: The stock has -2.00%.Past 6 Months: 2293 shares have -2.00%. Last updated: December 31, 2025 at 11:57 PM Eastern Time
Over the last year, Bamboos Health Care Holdings (2293) has established a 52-week price range between a high of HK$0.75 and a low of HK$0.49. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:57 PM Eastern Time
Bamboos Health Care Holdings (2293) is considered a low volatility stock. It has a beta of -0.09, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 0.09 times the market's movement. Over the past 52 weeks, 2293 has traded within a HK$0.49 – HK$0.75 range. Last updated: December 31, 2025 at 11:57 PM Eastern Time
A HK$1,000 investment in Bamboos Health Care Holdings 5 years ago, when the stock was trading around HK$0.78, would be worth approximately HK$628.16 today, based solely on share price performance (excluding dividends). This represents a total return of -37.18% over the period, equivalent to a compound annual growth rate (CAGR) of -8.88%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:57 PM Eastern Time
The current Bamboos Health Care Holdings (2293) market capitalization is approximately HK$197.21M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Bamboos Health Care Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:57 PM Eastern Time
In the most recently reported quarter, Bamboos Health Care Holdings (2293) generated HK$17.47M in revenue, representing a -23.60% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 3:11 AM Eastern Time
In the most recently reported fiscal year, Bamboos Health Care Holdings (2293) generated net income of HK$17.54M, compared with HK$30.92M in the prior fiscal year, representing a -43.27% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 3:11 AM Eastern Time
According to its latest quarterly filing, Bamboos Health Care Holdings (2293) reported EBITDA of HK$5.47M, representing a -44.25% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 3:11 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.27x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 3:11 AM Eastern Time
Based on the latest available data, Bamboos Health Care Holdings (2293) is currently trading at a last twelve months (LTM) P/E ratio of 11.22x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 3:11 AM Eastern Time
In the most recently reported quarter, Bamboos Health Care Holdings (2293) revenue was HK$17.47M. Earnings per share (EPS) for the quarter were HK$0.01. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 3:11 AM Eastern Time
Based on the latest available analyst coverage, Bamboos Health Care Holdings (2293) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 3:11 AM Eastern Time
Like other publicly traded stocks, Bamboos Health Care Holdings (2293) shares are bought and sold on stock exchanges such as SEHK and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Bamboos Health Care Holdings (2293) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 2293 to your watchlist.
Bamboos Health Care Holdings trades under the ticker symbol 2293 on the SEHK stock exchange. The ticker 2293 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Bamboos Health Care Holdings (2293) employs approximately 80 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:57 PM Eastern Time
Bamboos Health Care Holdings (2293) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Bamboos Health Care Holdings (2293) stock peers based on overlapping products, services, and competitive dynamics:Premier Health of America (PHA)AMN Healthcare Services (AMN) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Bamboos Health Care Holdings.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.